Altimmune, Inc.

Ticker ALT

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

51-200 Employees
Based in Gaithersburg, Maryland

Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Their diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an intranasal immune modulating therapeutic for COVID-19 (T-COVID™); and next generation peptide…More

Visit website

REPORT RATINGS

4.7 / 5.0 (172)

Altimmune, Inc. reports have an aggregate usefulness score of 4.7 based on 172 reviews.

Altimmune, Inc.